Mandana Rahbari

Appearances

METABOLIC BIOMARKERS PREDICT THE OUTCOME OF UDCA TREATMENT ON PBC PATIENTS WITH HIGH ACCURACY
Date
May 18, 2024
_BACKGROUND:_ Primary Biliary Cholangitis (PBC) is a cholestatic liver disease characterized by chronic inflammation and granulomatous destruction of interlobular bile ducts…
Presenter
Mandana Rahbari
Speakers
Sandra O'Keefe
Robert Tso
Tracy Jordan
Victor Tso
Andrew Mason
Human and Experimental Cholestasis
Date
May 18, 2024
METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Moderators
Heather Francis
Indiana University
Lily Dara
University of Southern California
Speakers
Alan Bonder
Robert Gish
University of Nevada Las Vegas School of Medicine
Alejandra Rodriguez-Sosa
Mandana Rahbari
Xue Zhang
Hao Jia